Soleno

Soleno company information, Employees & Contact Information

Explore related pages

Related company profiles:

1st developer of solutions for mastering water sustainably. Soleno is everywhere—under our roads, neighbourhoods, homes and fields. As the first developer of sustainable solutions, we have become established as masters of storm water management for the infrastructure, residential, natural resource and agricultural development sectors. From incomparable expertise and outstanding technical service to environmentally responsible practices, find out what makes Soleno a business partner of choice.

Company Details

Employees
214
Founded
-
Address
1160 Route 133, Saint-Jean-Sur-Richelieu,québec J2x 4b6,canada
Phone
+1 450 347 7855
Email
in****@****eno.com
Industry
Plastics Manufacturing
NAICS
Plastics Product Manufacturing
Plastics Packaging Materials and Unlaminated Film and Sheet Manufacturing
Plastics Pipe, Pipe Fitting, and Unlaminated Profile Shape Manufacturing
Laminated Plastics Plate, Sheet (except Packaging), and Shape Manufacturing
Polystyrene Foam Product Manufacturing
Urethane and Other Foam Product (except Polystyrene) Manufacturing
Plastics Bottle Manufacturing
Other Plastics Product Manufacturing
Plastics Bag and Pouch Manufacturing
Unlaminated Plastics Film and Sheet (except Packaging) Manufacturing
Unlaminated Plastics Profile Shape Manufacturing
Plastics Pipe and Pipe Fitting Manufacturing
Plastics Plumbing Fixture Manufacturing
All Other Plastics Product Manufacturing
Website
soleno.com
HQ
Saint-Jean-sur-Richelieu, Québec
Looking for a particular Soleno employee's phone or email?

Soleno Questions

News

Soleno Stock: Blockbuster Launch In Progress (NASDAQ:SLNO) - Seeking Alpha

Soleno Stock: Blockbuster Launch In Progress (NASDAQ:SLNO) Seeking Alpha

Soleno Therapeutics (SLNO) Drops Amid Critical Scorpion Report -- Hagens Berman - GlobeNewswire

Soleno Therapeutics (SLNO) Drops Amid Critical Scorpion Report -- Hagens Berman GlobeNewswire

Soleno Therapeutics responds to short seller’s Prader-Willi drug safety claims - statnews.com

Soleno Therapeutics responds to short seller’s Prader-Willi drug safety claims statnews.com

Soleno Therapeutics Stock Tanks After Patient Treated With Drug Dies – More Details Inside - Stocktwits

Soleno Therapeutics Stock Tanks After Patient Treated With Drug Dies – More Details Inside Stocktwits

SOLENO (SLNO) REMINDER: Bragar Eagel & Squire, P.C. Reminds - GlobeNewswire

SOLENO (SLNO) REMINDER: Bragar Eagel & Squire, P.C. Reminds GlobeNewswire

Soleno Wins First FDA Approval for Hyperphagia in Prader-Willi Syndrome - BioSpace

Soleno Wins First FDA Approval for Hyperphagia in Prader-Willi Syndrome BioSpace

Soleno breaks through with FDA nod for Prader-Willi syndrome treatment Vykat XR - Fierce Pharma

Soleno breaks through with FDA nod for Prader-Willi syndrome treatment Vykat XR Fierce Pharma

Soleno Under Serious Scrutiny As Short Seller Alleges PWS Drug Is Overpriced, Unsafe - Benzinga

Soleno Under Serious Scrutiny As Short Seller Alleges PWS Drug Is Overpriced, Unsafe Benzinga

Soleno Therapeutics' 'life-changing' rare-disease drug approved | STAT - statnews.com

Soleno Therapeutics' 'life-changing' rare-disease drug approved | STAT statnews.com

Soleno Therapeutics: FDA Approval May Prove To Be A Pyrrhic Victory (NASDAQ:SLNO) - Seeking Alpha

Soleno Therapeutics: FDA Approval May Prove To Be A Pyrrhic Victory (NASDAQ:SLNO) Seeking Alpha

Soleno Therapeutics to Participate in Upcoming September Conferences - GlobeNewswire

Soleno Therapeutics to Participate in Upcoming September Conferences GlobeNewswire

Soleno Therapeutics Appoints Biopharmaceutical Executive Mark W. Hahn to its Board of Directors - Yahoo Finance

Soleno Therapeutics Appoints Biopharmaceutical Executive Mark W. Hahn to its Board of Directors Yahoo Finance

Soleno Therapeutics - Fierce Pharma

Soleno Therapeutics Fierce Pharma

SLNO Investor News: If You Have Suffered Losses in Soleno - GlobeNewswire

SLNO Investor News: If You Have Suffered Losses in Soleno GlobeNewswire

Soleno Therapeutics Announces Proposed $200 Million Public Offering of Common Stock - GlobeNewswire

Soleno Therapeutics Announces Proposed $200 Million Public Offering of Common Stock GlobeNewswire

Soleno Therapeutics Announces Pricing of $200 Million Public Offering of Common Stock - GlobeNewswire

Soleno Therapeutics Announces Pricing of $200 Million Public Offering of Common Stock GlobeNewswire

Soleno Therapeutics Announces Preliminary Financial and - GlobeNewswire

Soleno Therapeutics Announces Preliminary Financial and GlobeNewswire

Soleno Therapeutics Announces Submission and EMA Validation of Marketing Authorization Application for Diazoxide Choline Prolonged-Release Tablets for the Treatment of Hyperphagia in Patients with Prader-Willi Syndrome - GlobeNewswire

Soleno Therapeutics Announces Submission and EMA Validation of Marketing Authorization Application for Diazoxide Choline Prolonged-Release Tablets for the Treatment of Hyperphagia in Patients with Prader-Willi Syndrome GlobeNewswire

Soleno Therapeutics Enters Into $200 Million Debt Financing with Oxford Finance LLC - GlobeNewswire

Soleno Therapeutics Enters Into $200 Million Debt Financing with Oxford Finance LLC GlobeNewswire

Soleno sales of new Prader-Willi drug rise faster than expected - BioPharma Dive

Soleno sales of new Prader-Willi drug rise faster than expected BioPharma Dive

Soleno Therapeutics Provides Update on U.S. Launch of - GlobeNewswire

Soleno Therapeutics Provides Update on U.S. Launch of GlobeNewswire

PANTHERx® Rare Selected by Soleno Therapeutics for the Distribution of VYKAT™ XR - PR Newswire

PANTHERx® Rare Selected by Soleno Therapeutics for the Distribution of VYKAT™ XR PR Newswire

Soleno Therapeutics Highlights New Data on VYKAT(TM) XR at the 2025 United in Hope: International Prader-Willi Syndrome Conference - Yahoo Finance

Soleno Therapeutics Highlights New Data on VYKAT(TM) XR at the 2025 United in Hope: International Prader-Willi Syndrome Conference Yahoo Finance

Why Soleno Therapeutics Inc. (SLNO) Went Up On Friday? - Yahoo Finance

Why Soleno Therapeutics Inc. (SLNO) Went Up On Friday? Yahoo Finance

TD Cowen Starts Coverage Soleno Therapeutics (SLNO) Stock, Gives Buy - Yahoo Finance

TD Cowen Starts Coverage Soleno Therapeutics (SLNO) Stock, Gives Buy Yahoo Finance

Soleno Therapeutics gains amind renewed takeover speculation (SLNO:NASDAQ) - Seeking Alpha

Soleno Therapeutics gains amind renewed takeover speculation (SLNO:NASDAQ) Seeking Alpha

SLNO Investors Have Opportunity to Join Soleno Therapeutics, Inc. Fraud Investigation with the Schall Law Firm - Business Wire

SLNO Investors Have Opportunity to Join Soleno Therapeutics, Inc. Fraud Investigation with the Schall Law Firm Business Wire

Soleno Therapeutics, Inc. Securities Lawsuit Investigation - Claim Depot

Soleno Therapeutics, Inc. Securities Lawsuit Investigation Claim Depot

Rare Disease Biotech Soleno Therapeutics Lines Up 5 Major Wall Street Healthcare Conference Presentations - Stock Titan

Rare Disease Biotech Soleno Therapeutics Lines Up 5 Major Wall Street Healthcare Conference Presentations Stock Titan

Soleno Therapeutics: Overbought On VYKAT Approval Enthusiasm (NASDAQ:SLNO) - Seeking Alpha

Soleno Therapeutics: Overbought On VYKAT Approval Enthusiasm (NASDAQ:SLNO) Seeking Alpha

Soleno Therapeutics: In No Rush To Join Buying Frenzy Despite Vykat Approval (SLNO) - Seeking Alpha

Soleno Therapeutics: In No Rush To Join Buying Frenzy Despite Vykat Approval (SLNO) Seeking Alpha

Soleno Therapeutics Announces U.S. FDA Approval of VYKAT(TM) XR to Treat Hyperphagia in Prader-Willi Syndrome - GlobeNewswire

Soleno Therapeutics Announces U.S. FDA Approval of VYKAT(TM) XR to Treat Hyperphagia in Prader-Willi Syndrome GlobeNewswire

Soleno Therapeutics plunges after short report from Scorpion Capital (SLNO:NASDAQ) - Seeking Alpha

Soleno Therapeutics plunges after short report from Scorpion Capital (SLNO:NASDAQ) Seeking Alpha

INVESTOR ALERT: Investigation of Soleno Therapeutics, Inc. (SLNO) Announced by Holzer & Holzer, LLC - GlobeNewswire

INVESTOR ALERT: Investigation of Soleno Therapeutics, Inc. (SLNO) Announced by Holzer & Holzer, LLC GlobeNewswire

Soleno Therapeutics Announces U.S. FDA Acceptance for - GlobeNewswire

Soleno Therapeutics Announces U.S. FDA Acceptance for GlobeNewswire

Quebec HDPE Pipe Maker Soleno Opens First U.S. Plant - Canadian Plastics

Quebec HDPE Pipe Maker Soleno Opens First U.S. Plant Canadian Plastics

Soleno Therapeutics Announces Pricing of Approximately $120 - GlobeNewswire

Soleno Therapeutics Announces Pricing of Approximately $120 GlobeNewswire

Soleno Therapeutics Announces Positive Statistically - GlobeNewswire

Soleno Therapeutics Announces Positive Statistically GlobeNewswire

Soleno Therapeutics And Acadia Pharmaceuticals: Hope For Prader–Willi Families (ACAD) - Seeking Alpha

Soleno Therapeutics And Acadia Pharmaceuticals: Hope For Prader–Willi Families (ACAD) Seeking Alpha

"Efficient Irrigation, forward thinking." - Hortidaily

"Efficient Irrigation, forward thinking." Hortidaily

Top Soleno Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant